Bibliographic data
`
`Title:
`
`Eye gel for atropine sulfate
`
`PubfPat no:
`
`CN1456161A
`
`Pub/"Issue Dates.
`
`2003-11—19
`
`hventofis);
`
`HDONG Ll lDONGlVHN YAO 1E GAO
`
`Applicant(s):
`
`LIU HDONGKEN]
`
`Classification:
`
`AGIKQJ'UOAI; A61K3L’46AI; A61P27/02AI
`
`Appligaiion number:
`
`CNN—2002 l 'l 7622.: 2002-05 -10
`
`Priority number:
`
`CN2002117622 2002-05-10;
`
`Abstract of CN1456161A
`
`An atropine sulfate gel for Examining eycground, enlarging pupil, and treating kerartitis and
`iridptiycliti‘s is prepared from atropine sulfate, hydroxypmpyl mathylcellulose‘, boric acid, bOrax
`
`and. phenylmethylhydroxy amine-chloride) Its advantagas are long stay time in eye,- and, high
`
`curative affect and biological utilization rats.
`
`
`
`Title:
`
`Eye gel for atropine sulfate
`
`PubfPat no:
`
`CN1456161A
`
`Pub/"Issue Dates.
`
`2003-11—19
`
`hventofis);
`
`HDONG Ll lDONGlVHN YAO 1E GAO
`
`Applicant(s):
`
`LIU HDONGKEN]
`
`Classification:
`
`AGIKQJ'UOAI; A61K3L’46AI; A61P27/02AI
`
`Appligaiion number:
`
`CNN—2002 l 'l 7622.: 2002-05 -10
`
`Priority number:
`
`CN2002117622 2002-05-10;
`
`Abstract of CN1456161A
`
`An atropine sulfate gel for Examining eycground, enlarging pupil, and treating kerartitis and
`iridptiycliti‘s is prepared from atropine sulfate, hydroxypmpyl mathylcellulose‘, boric acid, bOrax
`
`and. phenylmethylhydroxy amine-chloride) Its advantagas are long stay time in eye,- and, high
`
`curative affect and biological utilization rats.
`
`
`
`[19] filifikfifiifllfllfliiflififtflfi
`
`1
`;*
`*
`
`mlfim§fl$fifi%fimfi
`
`[21] Hafiz-E 02117622.1
`
`[51 ] Int. Cl7
`A61K 31/46
`
`A61K 9/00 A61P 27/02
`
`[43] fiiFEl
`
`
`2003 $11 E 19 El
`
`[11] ’A33FF'I; CN 1456161A
`
`[22] $1,355 2002.5.10
`
`[21] $1255; 021176221
`
`[71] Ehifik inJéEUE
`
`#12th
`
`
`110027 il?‘§%$fi%9¥fiifi3¥7il3£
`
`Féffi 12 EF' 4 %%Bfifii¥é?fifiw§7~ififififi
`
`E/AEJ
`
`[72] fififlk XUéEUE
`
`ZIJEEE
`
`E]
`
`111%
`
`fiEi’dfi
`
` Eli
`flflgflfi? 1 E 131%? 3 E W
`
`[54] 33.55%?51
`
`thfignjfifijfiflfifi7fifi
`
`[57] fig
`
`
`$fi5fl%fi#$¢§§%EA§kfififi—Efifimfi5‘:—
`
`
`E¥K$Ufiififlfifii§fi§fiifiuy fififi’éflqfiflxfiéififi’f’iflfififlfiffi
`
`M-HHWE‘E‘EXZ’QP EEXfifiZMHHWAZEMHHWZZJ—W
`
`M—§1ZI§§%Z%7M/3fifis E‘EfiMEFfiWEgs E‘Ewfiumi
`
`fififlfi?Lo ZFE'yifififigrEfifiWEfitFfiu
`
`1213513EZ‘,
`
`HZHEHQWEHQ, $afi$y€7fi§jfifififirwfififififix
`
`HE
`
`
`
`WT$%EE‘I‘EU%EE4JI‘EUEE; WEE,
`
`figéfitffifiéfifiifim
`
`EECWJiUmE,
`
`figbnfifizfnfifiéfifiéfio
`
`igfi'i/{Q
`
`Wfifé: fifimflfin ¥§W$§Z¥éfi§a fififlfiy
`
`EH3
`
`43¢, {ii-MUCX$1§H§$UE§Z$§EH§7X$§EEEW§L§W,
`
`{imEEfiEfi%fl#Ei§/fifigmfififi, {fimfgfiv
`
`£§m¥fiflfifigfigfifilfififififlfifififi1 HEfiFfiififififi
`
`fiEWEiifififiE, flflflm$fififlfifi\ ECHEEE
`
`313$,
`
`Wifiifiégrfi‘llyfific
`
`#mffiamfimm
`
`
`
`
`
`
`
`ISSN1008—4274
`
`
`
`02117622.1
`
`1‘2
`
`*U
`
`E5
`
`3}?
`
`3F}
`
`fil/IE
`
`1. #WfigTflflfifififigfifififififigflflfi, EEfl$7K7KFfiT§§Cfi, *Eflfiififi. FE
`
`Tfififié‘ flfififififigfififimfifimfiflflfifiiflflf¥fi$flfl: fiififfigfifi
`
`EWJ‘EIEIHEFHWES‘E: 443$sz 01 - (¥é$§) XZE - 8 - 55% ‘ 3%31KB‘ 2‘
`
`1] — 3- EEEEfififiE—mém; £138?!) Atropine sulfate ophthalmic gel;
`
`W‘FEEHT-E'jb Liusuan Atuopin Yanyongningjiao; fifiWErfiafifimfiflfifififiW
`
`fifiaflgfififlm, fifi‘r’fiflfléfifi'filfiflfi‘fififlfim» jip'fi'fiflfajbfififimfisfinfifl
`
`Ffififli‘ia fifimfifixéfiw5i§fiflfiififififi7<ifl ttfiléfifiifififlffifflflflfiffi
`
`mum: fidJ/a‘fifimfifljb 1.0% (w/w):
`
`€¥éfi$§fiéfi§fi
`
`4. 0% (w/w):
`
`€Hflfij§ o. 5% (w/w); 43001030 1.0% (w/w); fiiflsfifiafiififla 0.01% (w/w)°
`
`Elitjiimfififiafifiéfiimififififififififififi, §Ffio ElitfiEBng‘ Wfi
`
`MAE¢,fi#fl@,fififi%fi%Efi;MAQWX$EE,fifiEEfi:M
`
`Afifififlfin‘fififlfiflfififi, *l‘mfiéi, fifijfifiei’gffl; 515$: $133765, 53‘
`
`%. Ewan 7357f, fifififlfifififlfifififififififi$§figfifigfim $§ng$§§
`
`fiflk filfiggiflwggfifififfififififli fififigfiiflglfififififio ififi‘lfi
`
`IZFF, fifilbfififi: (DEWEpfigififififigrfl‘T (DH=5.0—6.0) WEE‘J’E
`
`mfiflfi, (2)5WER Wfigfiflfiifi‘flé’flflflfifi ORIEYETE 60—80°C) Efiifli
`
`ifiififlfifl‘fiéfi, (3)11flkfififimfirfi254fififlfififiifififiET (45-55°C) {523*
`
`fifl, «WHERE (115°C, 30 5mm).
`
`2.
`
`fifififlfifijfi; 1 fififlfifififififlfififififilfifi, fififlEfi‘fi‘fiwfififikfifi
`
`EWfifiafiytfiflfifiHEFfiififlfim, fiwsigfififizmzfifivmwamwmm
`
`THEfiBflEfiERSfifi'fifimfikflg. Bfiflifififififlfi, fifiw‘ntfli‘fi, mffilfi
`
`rfié flfiflififliflégfifififlfifififl: EfiPfififiBflfifinfiflfififififi, max:
`
`0. 5—5. 0%(w/w): iifififififififigfi-éfififi 0—20. 0%(w/W); ammfi 0-5. 0%
`
`(w/w); $33359 0—10. 0% (w/w); figwfig‘iéflfifi 0-0. 05% (w/w)o
`
`
`
`02117622.1
`
`11%.
`
`EH
`
`4:;
`
`fil/SE
`
`fifiifimffin‘hBEFfifiHi
`
`Effififififi
`
`
`
`ZifiififiR—fifliwfififififi—HEEWEEE
`
`E‘Ykfiflfififlfiffiififié. 52%
`
`fiififlfiifififififiifi. *lfifififlfififio iEEIW—Jfiffiafifit fifififififi$fifl9fi
`
`fie
`
`fifi‘fifi
`
`E WIIfiEEiFMiPflH‘fi‘L E51”1W9}, flflflfilfilfififfi 1. WEE? (uflififi
`
`Efi ); Eflfifififiifiqflfififli 1. 0%BEEM» fififl? 1. OWEWEnfiufiflflifio BE
`
`EWEIfinflflfiiifim‘éfl‘JfiZiififlfimfififlflifi. EflwgfimmflgEfififlfilfiPfififi
`
`filfl‘c‘fiflfi ( liliflflffi ), fililfib 33r§¥fill¥o mamfimmmzm E fiiffiiflfim
`
`937W EFE‘JTEJ‘EO
`
`2%“)? F9 5
`
`fiTE’EHfiéfi—fifii. DWfiMfiufifimfiEfiFfiflflZ‘E:
`
`film—“fiflfifiafim‘é,
`
`Efififififiéfi'fi, WflfiyéTfiflfiifiifimflififi,
`
`fiEVififiHI’E—flfiflgffilfi, Eli
`
`Jfififi, fifiéfiwfifiiflifiHQEMfllmE. igbflfififlfi'fifiéfio
`
`iiiifyifi‘lfififfifi: fifimffirfi‘zéfiwfiifiifififiqafifiéfifiififilfififik‘
`
`fiimfififiifii, mmfififlfiffififiugififififlfififi, 4431134???“ fififiififli
`
`fiD‘F:
`
`fifimfi&flflfifififli$fi$fl?flj. EH2: fifimi‘fifluflflfifiififlfi: wig: 0
`
`- (fiffig) 353E - 8 - 513E - figk‘XJWHB‘ 2‘ 1] - 3 - $EEE§EER~K€%:
`
`fiifi : Atropine sulfate ophthalmic gel; fiififi‘é: Liusuan Atuopin yanyong
`
`ningjiao; fifiWfiflflEfiififlifiJfififiWfiflfifl$7f$flfiL fififfiflfiflfigfiifififi
`
`$E#§5EB‘JJEWL fifiafibfigfififimi‘fiflflflfiififlfio fifiWfiflfifl—‘fiigfifilfi
`
`fiREETW thfiéflfiiifl‘lfl'ZFB—Fflfifififimfiflm: fiEP’filfiifiWEfidJ 0. 1—5. 0%
`
`
`
`02117622.1
`
`1%
`
`F93
`
`1F}
`
`fiZ/SE
`
`(w/W): fifififiigfiéfifiw 0-20. 0% (w/w); fiflfififi 0—5. 0% (w/w); emw
`
`%o&a%(wm;fifikfi$fifih0fimm(ww.mfififimfifi$£flfi
`
`imMMMfififiifi%,fifiofifififififlfl~W§MAE$.fi#fifl.
`
`flmfiwfifi£fi:MAEWKfififi,fififififi:MAfifiWfiflfi%fifl
`
`mfi.%m§éi.fififi#fl®;mamafififlfi,flgfifi,fi¥.Wfio
`
`%%,fifimfifl5fMWEfl‘$Efifiififlxfiafi§§fl%£fififlfi
`
`mfifl.fifi$§§$§§fl§fifi§§fioififl%12$,fiabfififi:
`
`mfifi$§fifi§fifi§fiT<wflnfin)ufififlmfi%,msmfl‘M$
`
`%fiflfififiém%fifi(fififiEmHMC>%%flfififi%%%fi.@MAfi
`
`fiWEflfiWfifilfi‘ifiifiF—jifiET (45~55°C) mfimm, «mama (115°C.
`
`30 Man,
`
`$fiflmfifim%:fifimfi%fi%fiwmfifi5%fifiung:uxfii
`
`mm%&wmfifififi¢m?fifi,%fifi€fiflfifi¢fi.flfifiumfiwm
`
`fififififi§%fiflfifififimfimuflxmfi$fifimmfim,fififlfififi
`
`HWfimfifioflfiflflfiWfififlfiflwmfifi$Efimfififi,EWWEE
`
`Wflfi.fifl?EEMEfimfiflfimzHflifififimmfifim,mfimfi&
`
`mmfiflmfififl.$gfifi.$E%K%.fimfifiofi~fifi,fifimfi&
`
`mmfifi$fimwfifim,Efiflflfifio$F&mfifimm.$flflfi%@fi
`
`mflmfim#m§5,fiflfifififi%fi%flfifléfififidfixfimfiflfim
`
`W%flmflfimfiifira.w$¢%#afifl¥mfimifi‘mfl\fifi,fi
`
`W§Mfi%fifi$fl,WflmfififiFfimmmuL°ifi%,fififififiwgfi
`
`BER aflwgmm (mi) 39%;? fifiéafio mfimfifiaflfimfifi—Efi
`
`fiflm,%%%&flfigiflfifimmflo
`
`iww
`
`fifih
`
`mmmfi&
`
`fifififififii
`
`Wfi
`
`Lofi
`
`¢0E
`
`LOE
`
`
`
`02117622.1
`
`fl%
`
`ma
`
`4%
`
`fifiB/Sfii
`
`WE
`
`fikfiWfiE
`
`Efimm
`
`fifififiz
`
`usfi
`
`amfi
`
`fimumfi
`
`®.mfifiimfifi$§§fiimfiifififimfik.flag
`
`®.Wfififimmw‘WEWAE¢.fififlfi.mmfiflfi%fifififi;
`
`®.mAfimX$fifi,fi#fififl;
`
`@.mAfi§WEfl,%m§éfi,fifififififi:
`
`©.mmmafififlm.mififi,fi£.wfio
`
`flfia
`
`fififlfi&
`
`%fi$§§$§
`
`wv
`
`WE
`
`fikfi$fifi
`
`Ewfifi
`
`fififlfl:
`
`ukaofi
`
`akmflfi
`
`akaofi
`
`kasfi
`
`QMflSE
`
`flfiumfi
`
`®.Wfifiimfifi$£§fifimfififififlmfi%yflan
`
`@.Wfifi§%%$~W§MAfi¢.fififiS,Mflfififiwfifi§fi;
`
`®.mAfi%X$fiE.fififififlz
`
`@.mAfi§W%&:%K§é§,fififi#fifl;
`
`(5). $220 afififififlfifi. #‘eEEBZE‘ fifi. EM?“
`
`xfiwmflfifi,fifi%$\fifififififi%¥m,ifiEéW~fififio
`
`E1fifi§fifi$fififikfl§limfiflo
`
`
`
`02117622.1
`
`iii
`
`HF]
`
`ZR"
`
`M1
`
`fil/IE
`
`IZEEE
`
` fik$$¥éfl§
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
